On April 1, the Biden administration released its strategic drug policy plan, amid an intensifying drug epidemic with escalating overdose deaths across the United States. The policy guidance embraces many elements advocated by the drug reform policy community, such as enhancing evidence-based harm reduction efforts and expanding access to treatment. Among the global community, Portugal has been a leader in implementing many of these priorities with positive results, and is widely considered a model of drug policy reform.
On April 27, Foreign Policy at Brookings and the Embassy of Portugal hosted a webinar on drug policy reform, trends in the United States and around the world, and lessons from Portugal. After opening remarks by Domingos Fezas Vital, ambassador of Portugal to the United States, Senior Fellow Vanda Felbab-Brown moderated a panel discussion.
After their remarks, panelist took questions from the audience. Viewers submitted questions via email to email@example.com or Twitter using #DrugPolicy.
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.
On February 24, Vanda Felbab-Brown joined the National Committee on US-China Relations for a discussion on “The faces of fentanyl: China, the United States, and those in-between.”